Nomura Adjusts RemeGen's Price Target to 27.82 Yuan From 52.87, Keeps at Neutral
Nomura Adjusts RemeGen's Price Target to 27.82 Yuan From 52.87, Keeps at Neutral
野村將榮昌生物的目標價從52.87元下調至27.82元,但維持中立評級。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊